$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,300 Today
Portfolio Pulse from Benzinga Insights
CRISPR Therapeutics (NASDAQ:CRSP) has delivered an average annual return of 17.73% over the past 5 years, outperforming the market by 4.96%. A $1000 investment in CRSP 5 years ago would now be worth $2,300. The company's current market capitalization stands at $5.54 billion.
February 09, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CRISPR Therapeutics has shown a strong performance over the past 5 years with an average annual return of 17.73%, significantly outperforming the market.
The significant outperformance of CRISPR Therapeutics compared to the market, as evidenced by its 17.73% average annual return over the past 5 years, suggests a strong growth trajectory and operational success. This historical performance, coupled with a substantial market capitalization of $5.54 billion, indicates a positive outlook for the company's stock in the short term. Investors may view this track record as a sign of the company's robust fundamentals and potential for continued growth.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100